Observational studyJournal of neurointerventional surgery2020

Periprocedural to 1-year safety and efficacy outcomes with the Pipeline Embolization Device with Shield technology for intracranial aneurysms: a prospective, post-market, multi-center study.

Hal Rice et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.